Publications by authors named "Edward Michael Chan"

Claim this Profile
P
Phase 1 study of abemaciclib, an inhibitor of CDK 4 and 6, as a single agent for Japanese patients with advanced cancer.
Yutaka Fujiwara, Kenji Tamura, Shunsuke Kondo, Yuko Tanabe, Satoru Iwasa, Edward Michael Chan

Cancer Chemother Pharmacolยท August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis